Nonthavej Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,372	2,484	2,472	2,255	1,786
Other Revenue	13.7	15.57	13.19	14.83	16.13
Revenue	2,386	2,500	2,485	2,270	1,802
Revenue Growth (YoY)	-4.56%	0.61%	9.45%	25.98%	-4.76%
Cost of Revenue	1,735	1,744	1,707	1,599	1,345
Gross Profit	651.06	755.76	777.82	671.24	457.29
Selling, General & Admin	329.43	328.42	311.51	290.96	262.07
Operating Expenses	327.5	325.21	306.18	300.65	266.56
Operating Income	323.56	430.55	471.64	370.59	190.73
Interest & Investment Income	21.72	19.02	11.69	4.54	3.56
EBT Excluding Unusual Items	345.29	449.57	483.33	375.13	194.3
Gain (Loss) on Sale of Investments	-0.03	-0.17	-0.08	-0.19	0.19
Pretax Income	345.25	449.4	483.25	374.94	194.49
Income Tax Expense	68.5	88.66	95.5	74.37	35.12
Net Income	276.76	360.74	387.75	300.56	159.37
Net Income to Common	276.76	360.74	387.75	300.56	159.37
Net Income Growth	-23.28%	-6.96%	29.01%	88.59%	-30.95%
Shares Outstanding (Basic)	160	160	160	160	160
Shares Outstanding (Diluted)	160	160	160	160	160
EPS (Basic)	1.73	2.25	2.42	1.88	1.00
EPS (Diluted)	1.73	2.25	2.42	1.88	1.00
EPS Growth	-23.28%	-6.96%	29.01%	88.59%	-30.95%
Free Cash Flow	202.49	356.72	408.45	379.07	111.13
Free Cash Flow Per Share	1.27	2.23	2.55	2.37	0.69
Dividend Per Share	1.040	1.370	1.460	1.130	0.600
Dividend Growth	-24.09%	-6.16%	29.20%	88.33%	-31.03%
Gross Margin	27.29%	30.23%	31.30%	29.57%	25.38%
Operating Margin	13.56%	17.22%	18.98%	16.32%	10.58%
Profit Margin	11.60%	14.43%	15.60%	13.24%	8.84%
Free Cash Flow Margin	8.49%	14.27%	16.44%	16.70%	6.17%
EBITDA	514.6	607.88	638.39	545.47	348.04
EBITDA Margin	21.57%	24.32%	25.69%	24.03%	19.31%
D&A For EBITDA	191.04	177.33	166.75	174.88	157.3
EBIT	323.56	430.55	471.64	370.59	190.73
EBIT Margin	13.56%	17.22%	18.98%	16.32%	10.58%
Effective Tax Rate	19.84%	19.73%	19.76%	19.84%	18.06%
Revenue as Reported	2,386	2,500	2,485	2,270	1,802

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.